Health Trials

About this trial

Nearly half of adults in the United States have or are at risk of developing type 2 diabetes. The overall goal of this community-engaged research is to examine the efficacy of an innovative couple-based lifestyle intervention to prevent type 2 diabetes that is applicable to a broad range of partnered adults in the United States. By simultaneously targeting lifestyle and perceived support from romantic partners, there is a high likelihood of creating lasting changes in both

Eligibility criteria

Qualifiers

BMI ≥ 25 kg/m² (≥ 23 kg/m² if Asian American), and

Do not have a diagnosis of type 1 or type 2 diabetes, and

Not currently pregnant, and

High risk for type 2 diabetes based on: (i) CDC Prediabetes Risk Test score ≥ 5, (ii) clinically diagnosed Gestational Diabetes during a previous pregnancy (for women), or (iii) a blood test result indicative of prediabetes in the past year (i.e., fasting blood glucose 100-125 mg/dl; plasma glucose 140-199 mg/dl measured 2 hours after a 75 g glucose load; or HbA1c 5.7%-6.4%).

Disqualifiers

"Supporting partner" has a diagnosis of Type 2 Diabetes.

Has a diagnosis of another chronic disease (unless no major events/changes for 3+ months), or

Is currently on medication or engaged in lifestyle intervention for prediabetes or obesity, or

Has previously participated in the National DPP, or

Trial design

Treatments tested in this trial

  • Individual intervention condition (PreventT2)
  • Couple-based intervention condition (PreventT2 Together; couple-based adaptation of 2021 PreventT2; approved by the CDC in November 2022 as an Alternate Curriculum for use in the NDPP)

Treatment groups

324 Participants
are divided into 2 treatment groups

Locations

1
University of Utah84112, Salt Lake CityUtah, United States

Sponsors and collaborators

University of Utah

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Source ClinicalTrials.gov